In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.
about
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction.Derivation of a respiration trigger signal in small animal list-mode PET based on respiration-induced variations of the ECG signal.Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [(18)F]FDG MicroPET.
P2860
In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@en
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@nl
type
label
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@en
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@nl
prefLabel
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@en
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@nl
P2093
P2860
P1476
In-vivo monitoring of erythrop ...... a]Annexin A5 and [¹⁸F]FDG PET.
@en
P2093
Andrei Todica
Carmen Wängler
Guido Böning
Marcus Hacker
Mathias J Zacherl
Michael C Kreissl
Nathalie L Jansen
Peter Bartenstein
Sebastian Lehner
P2860
P2888
P304
P356
10.1007/S12350-014-9987-0
P577
2014-09-05T00:00:00Z